(RTTNews) - Choice Hotels International, Inc. (CHH), a lodging franchisor, Wednesday said it has agreed to acquire RV travel membership company Harvest Hosts from Stripes and other shareholders for an enterprise value of approximately $130 million.
(RTTNews) - Canadian stocks are seen opening on a positive note on Wednesday, as firm crude oil and precious metals prices point to some buying in energy and materials sectors.
(RTTNews) - After ending yesterday's choppy trading session modestly lower, stocks are likely to move to the upside in early trading on Wednesday. The major index futures are currently pointing to a higher open for the markets, with the S&P 500 futures up by 0.4 percent.
(RTTNews) - CeriBell, Inc. (CBLL) said the FDA has cleared new software for its Ceribell System designed to simplify the interpretation of brain activity and help clinicians monitor patients more efficiently at the bedside.
(RTTNews) - Revised data released by the Commerce Department on Wednesday showed the U.S. economy grew by much more than previously estimated in the second quarter of 2026.
(RTTNews) - The Commerce Department released a closely watched report on Wednesday showing consumer prices in the U.S. rose by slightly less than expected in the month of August.
(RTTNews) - On Wednesday, AEON Biopharma (AEON) said feedback from a Type 2b meeting with the U.S. Food and Drug Administration (FDA) provided further clarity on the development pathway for ABP-450 as a biosimilar to BOTOX.
(RTTNews) - Eli Lilly (LLY) said EBGLYSS (lebrikizumab-lbkz) met the primary and secondary endpoints in the Phase 3b ADtouch study, showing significant improvements in skin clearance, itch and pain among adults and adolescents with moderate-to-severe hand and foot atopic dermatit
(RTTNews) - Wednesday, AEON Biopharma (AEON) said FDA feedback from a Type 2b meeting provided clarity on the development pathway for ABP-450 as a biosimilar to BOTOX.
The NASDAQ 100 Pre-Market Indicator is up 110.77 to 30,450.1. The total Pre-Market volume is currently 145,772,447 shares traded.The following are the most active stocks for the pre-market session: Capricor Therapeutics, Inc. (CAPR) is +1.15 at $9.72, with 6,147,525 shares trade
(RTTNews) - On Wednesday, Satellos Bioscience (MSLE) said it has completed enrollment in BASECAMP, a Phase 2 clinical trial evaluating forazapadin for the treatment of Duchenne muscular dystrophy (DMD) in ambulatory boys aged 7 to 10 years.